Event Details

The company has scheduled a conference call with analysts and investors to discuss its unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 FY27).

Conference Call Schedule

  • Day and Date: Friday, October 16, 2026
  • Time: 04:00 PM IST
  • Meeting Type: Conference Call - Group Meet
  • Scheduled for: Investors/Analysts

Management Participants

The conference call will feature:

  • Sandeep Rao, Managing Director & Chief Executive Officer
  • Sarat Kumar, Chief Financial Officer

Dial-in Details

  • Universal Access Numbers: +91 22 6280 1346, +91 22 7115 8247
  • Diamond Pass (for early registration): Available via provided link

Additional Information

The conference call information will also be available on the company's website at: https://solara.co.in/investor-relations/schedule-of-investors-meet-and-investors-presentations/

Company Description

The document describes the company as "Pure play APIs" (Active Pharmaceutical Ingredients).

#Tags: #SolaraActivePharmaSciences #Q2FY27Results #InvestorConferenceCall #SEBIDisclosure #RegulatoryCompliance #Neutral